Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization (Q33337811)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization |
scientific article |
Statements
1 reference
Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization (English)
1 reference
1 reference
G W Stone
1 reference
D J Moliterno
1 reference
H C Herrmann
1 reference
E R Powers
1 reference
C L Grines
1 reference
D J Cohen
1 reference
E A Cohen
1 reference
M Bertrand
1 reference
F J Neumann
1 reference
P M DiBattiste
1 reference
L Demopoulos
1 reference
TARGET Investigators. Do Tirofiban and ReoPro Give Similar Efficacy Trial
1 reference
1 June 2001
1 reference
1 reference
344
1 reference
25
1 reference
1888-1894
1 reference
Identifiers
1 reference
1 reference